Skip to main content
. 2016 Jun 21;115(3):391–400. doi: 10.1038/bjc.2016.177

Table 3. Age-standardised estimates of 1- and 5-year net survival by cancer, stage, and staging strategy.

  Non-restrictive staging strategy Restrictive staging strategy
Stage NS (CI) NS (CI)
Colorectal cancer
One-year net survival    
 I 0.979 (0.976, 0.981) 0.982 (0.978, 0.985)
 II 0.936 (0.933, 0.939) 0.949 (0.945, 0.952)
 III 0.880 (0.877, 0.883) 0.898 (0.893, 0.902)
 IV 0.495 (0.489, 0.501) 0.510 (0.504, 0.515)
 Missing 0.605 (0.599, 0.612) 0.777 (0.774, 0.780)
Five-year net survival    
 I 0.952 (0.944, 0.960) 0.957 (0.945, 0.969)
 II 0.849 (0.843, 0.855) 0.861 (0.852, 0.871)
 III 0.638 (0.632, 0.645) 0.665 (0.655, 0.674)
 IV 0.152 (0.146, 0.157) 0.158 (0.152, 0.164)
 Missing 0.414 (0.406, 0.423) 0.619 (0.614, 0.624)
Lung cancer
One-year net survival    
 I 0.843 (0.837, 0.848) 0.852 (0.846, 0.858)
 II 0.685 (0.675, 0.695) 0.693 (0.683, 0.704)
 III 0.431 (0.425, 0.437) 0.439 (0.433, 0.445)
 IV 0.182 (0.179, 0.185) 0.183 (0.180, 0.186)
 Missing 0.256 (0.250, 0.262) 0.298 (0.293, 0.303)
Five-year net survival    
 I 0.542 (0.531, 0.554) 0.541 (0.529, 0.554)
 II 0.325 (0.310, 0.340) 0.325 (0.309, 0.341)
 III 0.099 (0.094, 0.104) 0.100 (0.095, 0.105)
 IV 0.025 (0.024, 0.027) 0.026 (0.024, 0.028)
 Missing 0.093 (0.088, 0.098) 0.125 (0.120, 0.130)

Abbreviations: CI, confidence interval; NS, net survival. Diagnoses in England, 2008–2012.